These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 9840826)

  • 21. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging.
    Stadlbauer A; Gruber S; Nimsky C; Fahlbusch R; Hammen T; Buslei R; Tomandl B; Moser E; Ganslandt O
    Radiology; 2006 Mar; 238(3):958-69. PubMed ID: 16424238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-dimensional proton MR spectroscopic imaging of premature and term neonates.
    Vigneron DB; Barkovich AJ; Noworolski SM; von dem Bussche M; Henry RG; Lu Y; Partridge JC; Gregory G; Ferriero DM
    AJNR Am J Neuroradiol; 2001 Aug; 22(7):1424-33. PubMed ID: 11498441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reproducibility of 1H-MRS in vivo.
    Brooks WM; Friedman SD; Stidley CA
    Magn Reson Med; 1999 Jan; 41(1):193-7. PubMed ID: 10025629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multiscale approach for analyzing in vivo spectroscopic imaging data.
    Zhang X; Heberlein K; Sarkar S; Hu X
    Magn Reson Med; 2000 Mar; 43(3):331-4. PubMed ID: 10725873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton MRS: N-acetyl aspartate, creatine, and choline.
    Maton BM; Kuzniecky RI
    Adv Neurol; 2000; 83():253-9. PubMed ID: 10999207
    [No Abstract]   [Full Text] [Related]  

  • 26. Proton MR spectroscopy in clinical routine.
    Burtscher IM; Holtås S
    J Magn Reson Imaging; 2001 Apr; 13(4):560-7. PubMed ID: 11276100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo T(2) relaxation time measurement with echo-time averaging.
    Prescot AP; Shi X; Choi C; Renshaw PF
    NMR Biomed; 2014 Aug; 27(8):863-9. PubMed ID: 24865447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton T2 relaxation of cerebral metabolites during transient global ischemia in rat brain.
    Fujimori H; Michaelis T; Wick M; Frahm J
    Magn Reson Med; 1998 Apr; 39(4):647-50. PubMed ID: 9543428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automatic repositioning of MRSI voxels in longitudinal studies: impact on reproducibility of metabolite concentration measurements.
    Ratai EM; Hancu I; Blezek DJ; Turk KW; Halpern E; González RG
    J Magn Reson Imaging; 2008 May; 27(5):1188-93. PubMed ID: 18425834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reproducibility of in vivo metabolite quantification with proton magnetic resonance spectroscopic imaging.
    Chard DT; McLean MA; Parker GJ; MacManus DG; Miller DH
    J Magn Reson Imaging; 2002 Feb; 15(2):219-25. PubMed ID: 11836781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Automated MR spectroscopy of intra- and extraventricular neurocytomas.
    Ueda F; Suzuki M; Matsui O; Uchiyama N
    Magn Reson Med Sci; 2007; 6(2):75-81. PubMed ID: 17690537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scan time reduction in proton magnetic resonance spectroscopic imaging of the human brain.
    Golay X; Gillen J; van Zijl PC; Barker PB
    Magn Reson Med; 2002 Feb; 47(2):384-7. PubMed ID: 11810683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton NMR chemical shifts and coupling constants for brain metabolites.
    Govindaraju V; Young K; Maudsley AA
    NMR Biomed; 2000 May; 13(3):129-53. PubMed ID: 10861994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proton MR spectroscopy of the brain at 3 T: an update.
    Di Costanzo A; Trojsi F; Tosetti M; Schirmer T; Lechner SM; Popolizio T; Scarabino T
    Eur Radiol; 2007 Jul; 17(7):1651-62. PubMed ID: 17235536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton magnetic resonance spectroscopy (MRS) of metastatic brain tumors: variations of metabolic profile.
    Chernov MF; Hayashi M; Izawa M; Ono Y; Hori T
    Int J Clin Oncol; 2006 Oct; 11(5):375-84. PubMed ID: 17058135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Manually adjusted versus vendor-preset definition of metabolite boundaries impact on proton metabolite ratios.
    Petrou M; Sundgren PC; Pang Y; Rohrer S; Foerster B; Chenevert TL
    Acad Radiol; 2007 Mar; 14(3):340-3. PubMed ID: 17307667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton magnetization transfer of metabolites in human brain.
    Meyerhoff DJ
    Magn Reson Med; 1999 Sep; 42(3):417-20. PubMed ID: 10467283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral volumes and spectroscopic proton metabolites on MR: is sex important?
    Wilkinson ID; Paley MN; Miszkiel KA; Hall-Craggs MA; Kendall BE; Chinn RJ; Harrison MJ
    Magn Reson Imaging; 1997; 15(2):243-8. PubMed ID: 9106152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TE-averaged two-dimensional proton spectroscopic imaging of glutamate at 3 T.
    Srinivasan R; Cunningham C; Chen A; Vigneron D; Hurd R; Nelson S; Pelletier D
    Neuroimage; 2006 May; 30(4):1171-8. PubMed ID: 16431138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of relaxation time corrections for the evaluation of long and short echo time 1H MR spectra of the hippocampus by NUMARIS and LCModel techniques.
    Jírů F; Dezortová M; Burian M; Hájek M
    MAGMA; 2003 Nov; 16(3):135-43. PubMed ID: 14564645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.